Skip to content
  • Tuesday, 29 September 2026
  • 11:34 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • New Stanford Medicine Study Reveals Protein-Targeting Treatment Restores Lost Knee Cartilage and Prevents Osteoarthritis in Preclinical Trials
Stem Cell & Regenerative Medicine

New Stanford Medicine Study Reveals Protein-Targeting Treatment Restores Lost Knee Cartilage and Prevents Osteoarthritis in Preclinical Trials

Dwi Wanna Sep 26, 2026 0

A groundbreaking scientific discovery led by researchers at Stanford Medicine has demonstrated that targeting a specific protein linked to the…

Read More
Stem Cell & Regenerative Medicine

Targeting the Protein of Time: Stanford Researchers Restore Knee Cartilage and Prevent Arthritis in Mice, Offering Hope for Human Joint Regeneration

Dwi Wanna Sep 18, 2026 0

A groundbreaking medical study led by researchers at Stanford Medicine has demonstrated that targeting a specific protein linked to the…

Read More
Stem Cell & Regenerative Medicine

Blocking a Protein Linked to Aging Restores Lost Knee Cartilage and Prevents Arthritis in Stanford Medicine Study

Dwi Wanna Sep 11, 2026 0

Researchers at Stanford Medicine have reported a significant preclinical breakthrough in regenerative medicine, identifying a therapeutic pathway that successfully restores…

Read More
Laboratory Automation & Robotics

Retatrutide eases sleep apnea and knee arthritis in new Phase 3 data, extending Lilly’s obesity lead over Novo

Lana Keisha Jul 18, 2026 0

Eli Lilly and Company has announced groundbreaking Phase 3 results for its investigational triple agonist, retatrutide, demonstrating significant efficacy in…

Read More
Laboratory Automation & Robotics

Retatrutide eases sleep apnea and knee arthritis in new Phase 3 data, extending Lilly’s obesity lead over Novo

Lana Keisha Jul 11, 2026 0

Eli Lilly has significantly bolstered its position in the competitive metabolic disease landscape with detailed Phase 3 results for its…

Read More
Laboratory Automation & Robotics

Retatrutide eases sleep apnea and knee arthritis in new Phase 3 data, extending Lilly’s obesity lead over Novo

Lana Keisha Jul 1, 2026 0

Eli Lilly and Company utilized the prestigious platform of the American Diabetes Association’s (ADA) annual meeting to unveil groundbreaking Phase…

Read More
Stem Cell & Regenerative Medicine

Stanford Medicine Researchers Identify Protein Inhibitor That Regenerates Lost Knee Cartilage and Reverses Osteoarthritis Damage

Dwi Wanna Jun 28, 2026 0

In a landmark study that could redefine the treatment of degenerative joint diseases, a research team led by Stanford Medicine…

Read More
Laboratory Automation & Robotics

Retatrutide eases sleep apnea and knee arthritis in new Phase 3 data, extending Lilly’s obesity lead over Novo

Lana Keisha Jun 22, 2026 0

The Dawn of a New Era in Metabolic Disease Management The announcement at the ADA meeting highlighted retatrutide’s remarkable efficacy,…

Read More
Stem Cell & Regenerative Medicine

Stanford University Study Reveals Gerozyme Inhibitor Capable of Regenerating Damaged Knee Cartilage and Halting Osteoarthritis Progression

Dwi Wanna Jun 20, 2026 0

A groundbreaking study led by researchers at Stanford Medicine has identified a therapeutic pathway that restores lost knee cartilage in…

Read More
Laboratory Automation & Robotics

Retatrutide Eases Sleep Apnea and Knee Arthritis in New Phase 3 Data, Extending Lilly’s Obesity Lead Over Novo

Lana Keisha Jun 15, 2026 0

Eli Lilly announced groundbreaking detailed Phase 3 results for its investigational triple agonist, retatrutide, at the American Diabetes Association’s (ADA)…

Read More

Posts pagination

1 2
Astrocyte networks in mice link distant brain regions in ways nerve cell wiring does notTWiV 1290: Clinical update with Dr. Daniel GriffinAs the dream of the autonomous clinical trial dawns, agent supervision is today’s human jobThe Century-Long Journey of Vitamin B12 From Fatal Anemia to Mitochondrial Energy Breakthroughs
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ